Newly Published Preclinical Study Demonstrates CD38 as a Driver of Age-Related NAD+ Decline, Older Mothers Have Lower NAD+ Levels in Placental Tissue, and NAD+ Restoration with Nicotinamide Riboside (

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/28/2026

1. NVDA
2. SPCX
3. META
4. MDB
5. MU
6. KOD
7. USO
8. LLY
9. SPY
10. MIRM

Go back to Newly Published Preclinical Study Demonstrates CD38 as a Driver of Age-Related NAD+ Decline, Older Mothers Have Lower NAD+ Levels in Placental Tissue, and NAD+ Restoration with Nicotinamide Riboside (
(NASDAQ: NAGE) Delayed: 2.98 -0.07 (2.3%)
Previous Close $3.05    52 Week High $ 
Open $3.04    52 Week Low $ 
Day High $3.07    P/E N/A 
Day Low $2.94    EPS $ 
Volume 411,442